AHA omega-3 statement
This article was originally published in The Tan Sheet
Executive Summary
"Evidence from prospective secondary prevention trials suggests" eicosapentaenoic acid plus docosahexaenoic acid "significantly reduce subsequent cardiac and all-cause mortality," AHA scientific statement in Nov. 19 Circulation says. Penny Kris-Etherton, PhD, et al., suggest while a dietary approach to increase omega-3 fatty acid intake "is preferable," supplements may be considered for those who cannot consume the recommended .5 g/d to 1.8 g/d through fish alone. However, researchers note "additional studies are needed to confirm and further define the health benefits of omega-3 fatty acid supplements for both primary and secondary prevention" of coronary disease. Patients taking more than 3 g of EPA + DHA from supplements "should do so only under a physician's care," Kris-Etherton et al. add...
You may also be interested in...
OMB omega-3 request
OMB urges HHS, USDA to modify the Dietary Guidelines and Food Guide Pyramid to include new information stating omega-3 fatty acids may reduce the risk of coronary heart disease, while trans fatty acids may increase risk of CHD, according to May 28 1"prompt" letter. OMB bases its request on "epidemiologic and clinical studies finding that an increase in consumption of omega-3 fatty acids results in reduced deaths due to CHD." OMB also points to American Heart Association's recent revision of its dietary guidelines to recommend eating fish, which is high in omega-3 fatty acids, twice weekly (2"The Tan Sheet" Dec. 2, 2002, In Brief). "Prompt" letter, which is used by Bush Administration to highlight issues considered worthy of priority status, requests meeting "in the next few weeks to discuss this issue"...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.